BFS
KYMR icon

Bare Financial Services’s Kymera Therapeutics KYMR Stock Holding History

Bare Financial Services’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Hold
25
– – ﹤0.01% 1048
2026
Q1 		$2.08K Sell
25
-25
-50% -$1.98K ﹤0.01% 966
2025
Q4 		$3.89K Buy
50
+29
+138% +$1.96K ﹤0.01% 625
2025
Q3 		$1.19K Hold
21
– – ﹤0.01% 969
2025
Q2 		$916 Buy
+21
New +$723 ﹤0.01% 943

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Bare Financial Services's KYMR Position: Q2 2026 in Review

Bare Financial Services held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 25 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Bare Financial Services first reported a position in KYMR in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.89K in Q4 2025. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Bare Financial Services held 25 shares of Kymera Therapeutics worth $2.87K as of Q2 2026.
  • Bare Financial Services left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1048 holding.
  • Bare Financial Services first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Bare Financial Services's Kymera Therapeutics position peaked at $3.89K in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.